pentoxifylline has been researched along with Fibrosarcoma in 8 studies
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline caused an increase in alkylator activity against the FSaIIC fibrosarcoma only when used with BCNU; this effect was further augmented by the addition of Fluosol-DA/carbogen." | 5.28 | Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma. ( Dezube, B; Frei, E; Herman, TS; Pardee, A; Tanaka, J; Teicher, BA, 1991) |
| "We hypothesized that the combination of pentoxifylline (PTX) and nicotinamide (NA) can reduce the radioresistance of FSaII murine fibrosarcoma by improving oxygenation of the hypoxic tumour cells." | 3.68 | Improved tumour oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline. ( Lee, I; Levitt, SH; Song, CW, 1993) |
| " The purpose of this study was to examine the effects of PENTO alone or in combination with NA (PENTO + NA) on the oxygenation and radio-response of FSaII murine fibrosarcomas of mice." | 1.28 | Increases in tumor response by pentoxifylline alone or in combination with nicotinamide. ( Kim, JH; Lee, I; Levitt, SH; Song, CW, 1992) |
| "Pentoxifylline caused an increase in alkylator activity against the FSaIIC fibrosarcoma only when used with BCNU; this effect was further augmented by the addition of Fluosol-DA/carbogen." | 1.28 | Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma. ( Dezube, B; Frei, E; Herman, TS; Pardee, A; Tanaka, J; Teicher, BA, 1991) |
| "Etoposide alone was essentially additive with the alkylating drugs for both tumor-cell and bone-marrow killing, except for BCNU, where a substantial increase in tumor-cell killing occurred (0." | 1.28 | Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo. ( Dezube, B; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fantin, M | 1 |
| Quintieri, L | 1 |
| Kúsz, E | 1 |
| Kis, E | 1 |
| Glavinas, H | 1 |
| Floreani, M | 1 |
| Padrini, R | 1 |
| Duda, E | 1 |
| Vizler, C | 1 |
| Ishibashi, T | 1 |
| Yamada, H | 1 |
| Harada, S | 1 |
| Harada, Y | 1 |
| Miyazaki, N | 1 |
| Takamoto, M | 1 |
| Watanabe, K | 1 |
| Price, MJ | 1 |
| Li, LT | 1 |
| Tward, JD | 1 |
| Bublik, I | 1 |
| McBride, WH | 1 |
| Lavey, RS | 1 |
| Takahashi, GW | 1 |
| Montgomery, RB | 1 |
| Stahl, WL | 1 |
| Crittenden, CA | 1 |
| Valentine, MA | 1 |
| Thorning, DR | 1 |
| Andrews, DF | 1 |
| Lilly, MB | 1 |
| Lee, I | 2 |
| Levitt, SH | 2 |
| Song, CW | 2 |
| Kim, JH | 1 |
| Teicher, BA | 2 |
| Herman, TS | 2 |
| Tanaka, J | 2 |
| Dezube, B | 2 |
| Pardee, A | 1 |
| Frei, E | 2 |
| Holden, SA | 1 |
8 other studies available for pentoxifylline and Fibrosarcoma
| Article | Year |
|---|---|
Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Li | 2006 |
Distant metastasis facilitated by BCG: spread of tumour cells injected in the BCG-primed site.
Topics: Animals; BCG Vaccine; Blood Cell Count; Erythrocytes; Female; Fibrosarcoma; Immunity; Iodine Radiois | 1980 |
Effect of nicotinamide and pentoxifylline on normal tissue and FSA tumor oxygenation.
Topics: Analysis of Variance; Animals; Drug Interactions; Fibrosarcoma; Male; Mice; Mice, Inbred C3H; Muscle | 1995 |
Pentoxifylline inhibits tumor necrosis factor-alpha-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells.
Topics: Animals; Cell Division; Cell Survival; Fibrosarcoma; Mice; Pentoxifylline; Phospholipases A; Phospho | 1994 |
Improved tumour oxygenation and radiosensitization by combination with nicotinamide and pentoxifylline.
Topics: Animals; Drug Combinations; Fibrosarcoma; Laser-Doppler Flowmetry; Mice; Microelectrodes; Niacinamid | 1993 |
Increases in tumor response by pentoxifylline alone or in combination with nicotinamide.
Topics: Animals; Cell Hypoxia; Combined Modality Therapy; Dose-Response Relationship, Radiation; Drug Therap | 1992 |
Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Bone Marrow; Carbon Dioxide; Cell Survival; Colon | 1991 |
Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; B | 1991 |